Public Notification on Pharmacovigilance
30 June, 2025

Public Notification on Pharmacovigilance

Share

If any adverse drug reaction (ADR) or adverse event following immunization (AEFI) is observed after using any medicine or non-injectable vaccine, please report the issue to the Directorate General of Drug Administration (DGDA) by filling out the Yellow Card form:

Online:
https://pvimsdashboard.com/yellow/card

Email:
adrnmcell.dgda@gmail.com

By Post:
Director (Pharmacovigilance),
Directorate General of Drug Administration (DGDA),
Mohakhali, Dhaka-1212, Bangladesh

Phone Number:
01928-394007

Website:
www.dgda.gov.bd

Annual Conference 2025 | CHQ & Plant